Call Options

9 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2022

May 16, 2022

BUY
$5.7 - $9.3 $36,480 - $59,520
6,400 Added 32.99%
25,800 $196,000
Q4 2021

Feb 14, 2022

BUY
$8.73 - $15.27 $169,362 - $296,238
19,400 New
19,400 $169,000
Q1 2021

May 17, 2021

SELL
$26.12 - $52.17 $295,156 - $589,521
-11,300 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$14.05 - $29.0 $158,765 - $327,700
11,300 New
11,300 $278,000
Q3 2020

Nov 16, 2020

SELL
$14.17 - $19.48 $113,360 - $155,840
-8,000 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$13.25 - $21.72 $21,200 - $34,752
1,600 Added 25.0%
8,000 $129,000
Q1 2020

May 15, 2020

SELL
$9.73 - $24.9 $42,812 - $109,560
-4,400 Reduced 40.74%
6,400 $92,000
Q4 2019

Feb 14, 2020

SELL
$14.22 - $23.38 $79,632 - $130,928
-5,600 Reduced 34.15%
10,800 $228,000
Q3 2019

Nov 14, 2019

BUY
$22.93 - $41.06 $376,052 - $673,384
16,400 New
16,400 $376,000

Others Institutions Holding CGC

About Canopy Growth Corp


  • Ticker CGC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 480,284,000
  • Market Cap $1.07B
  • Description
  • Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include d...
More about CGC
Track This Portfolio

Track Prelude Capital Management, LLC Portfolio

Follow Prelude Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.